HCV
Recap
Hepatitis C: Essential Treatment Considerations
Dr Elizabeth Verna shares HCV treatment updates for general practitioners, including a simplified HCV treatment algorithm, patient-...
Expert Interview
Improving access to liver disease screening in at-risk and underserved communities
Expert Interview
Transplanting Organs from Hepatitis C Virus Seropositive Donors to Hepatitis C Virus Seronegative Recipients
Expert Interview
Management of patients with HCV who fail first line DAA regimens
Expert Interview
HCV Special Populations: Effective Treatments, Addressing Unmet Needs, and Navigating COVID-19 with Dr. Hugo Rosen
Expert Interview
The Road to HCV Elimination with Joseph Lim, MD
Joseph Lim, MD, discusses the barriers that must be overcome in order to eliminate hepatitis C virus, including ensuring adequate treatment access...
Expert Interview
Overcoming hepatitis C treatment barriers: Dr. Sofia Simona Jakab shares VA insight
Sofia Simona Jakab, MD, is an attending hepatologist at Yale Medicine/Yale-New Haven Hospital and serves at...
From the Journals
Bioengineered liver models screen drugs and study liver injury
Advances in bioengineered livers will show improving sensitivity for the prediction of clinically relevant drug and disease outcomes.
Conference Coverage
Middle-aged hepatocellular carcinoma patients increasingly ineligible for transplant
WASHINGTON – Baby boomers show a disparity between high risk of HCC and low rate of meeting the Milan criteria.